 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Two prospective, peer reviewed trials demonstrate the symptomatic benefit of gammaCore in patients with PTSDROCKAWAY, N.J., Sept. 27, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a...

gammaCore Non-Invasive Vagus Nerve Stimulation (nVNS) Improves Attention and Working Memory in Patients with Post Traumatic Stress Disorder (PTSD)

ROCKAWAY, N.J., Sept. 26, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced the United States Patent and...

electroCore Expands Intellectual Property Portfolio for Non-Invasive Vagus Nerve Stimulation (nVNS) Technology

ROCKAWAY, N.J., Sept. 25, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan...

electroCore to Participate in the LD Micro Main Event XVI Conference

ROCKAWAY, N.J., Sept. 21, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan...

electroCore to Present at iAccess Alpha s   Top 10 Best Ideas from the Buyside Virtual Conference

ROCKAWAY, N.J., Sept. 07, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that Company CEO, Dan...

electroCore to Participate in the H.C. Wainwright 25th Annual Global Investment Conference

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

electroCore files to sell 1.09M shares of common stock for holders

electroCore announces dismissal of all litigation related to 2018 IPO

ROCKAWAY, N.J., Aug. 23, 2023 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic and wellness company, today announced that it has been completely vindicated in the securities class actions over the companys 2018 initial public offering brought in the federal and ...

electroCore Announces Dismissal of All Litigation Related to Its 2018 Initial Public Offering

electroCore (NASDAQ:ECOR  Get Free Report) and GigCapital5 (NYSE:GIA  Get Free Report) are both small-cap medical companies, but which is the superior stock? We will compare the two...

Analyzing electroCore (NASDAQ:ECOR) and GigCapital5 (NYSE:GIA)

electroCore, Inc. (NASDAQ:ECOR  Free Report)  HC Wainwright lifted their Q3 2023 earnings estimates for electroCore in a research report issued to clients and investors on Thursday...

Q3 2023 EPS Estimates for electroCore, Inc. Increased by Analyst (NASDAQ:ECOR)

electroCore, Inc. engages in the provision of non-invasive vagus nerve stimulation (nVNS) therapy. It develops a platform bioelectronic medical therapy that modulates neurotransmitters and immune function through its effects on both the peripheral and central nervous systems. The company was founded by Joseph P. Errico, Steven M. Mendez, Peter S. Staats and Thomas J. Errico in September 2005 and is headquartered in Rockaway, NJ.

Watchers	9,402
52-Wk Low	$2.92
52-Wk High	$7.50

Market Cap	$33.53M
Volume (M)	6,863.00
52-Wk High	$7.50
52-Wk Low	$2.92

ECOR ElectroCore Inc

About

Feed

News

Sentiment

Earnings

Fundamentals